Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience

Linda Sher, Linda Jennings, Steven Rudich, Sophoclis P. Alexopoulos, George Netto, Lewis Teperman, Milan Kinkhabwala, Robert S. Brown, Elizabeth Pomfret, Goran Klintmalm

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Chronic hepatitis C virus (HCV) is the most common disease indication for liver transplantation (LT). Outcomes are compromised by near universal recurrence of HCV. A prospective multi-center randomized study to evaluate immunosuppressive strategies in HCV+ transplant recipients provided the opportunity to assess impact of live donor (LD) LT. Two hundred and ninety-five patients undergoing LT for HCV (260 deceased donor [DD] recipients/35 LD recipients), randomized to three regimens, were followed for twoyr for patient and graft survival and rate and severity of recurrent HCV. Biopsies were performed at baseline, 3, 12, and 24months. One- and two-yr patient survival for LD recipients was 88.1% and 81.1% vs. 90.5% and 84.6% for DD recipients (p=0.5665). One- and two-yr graft survival for LD recipients was 82.9% and 76.2% vs. 87.9% and 81.7% for DD recipients (p=0.3921). Recurrent HCV did not account for more deaths or graft losses in the LD recipients. In this prospective study, controlled for immunosuppression, use of LD organs did not increase the rate or severity of HCV recurrence. The more elective nature of LDLT affords an opportunity to manipulate donor and recipient factors that can impact upon outcomes.

Original languageEnglish (US)
Pages (from-to)502-509
Number of pages8
JournalClinical Transplantation
Volume26
Issue number3
DOIs
StatePublished - May 1 2012

Keywords

  • Hepatitis C
  • Live donor liver transplant
  • Liver transplantation
  • Outcomes
  • Recurrence

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience'. Together they form a unique fingerprint.

  • Cite this

    Sher, L., Jennings, L., Rudich, S., Alexopoulos, S. P., Netto, G., Teperman, L., Kinkhabwala, M., Brown, R. S., Pomfret, E., & Klintmalm, G. (2012). Results of live donor liver transplantation in patients with hepatitic C virus infection: The HCV 3 trial experience. Clinical Transplantation, 26(3), 502-509. https://doi.org/10.1111/j.1399-0012.2011.01561.x